Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,025 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Post-exposure prophylaxis with SA58 (anti-SARS-COV-2 monoclonal antibody) nasal spray for the prevention of symptomatic COVID-19 in healthy adult workers: a randomized, single-blind, placebo-controlled clinical study.
Song R, Zeng G, Yu J, Meng X, Chen X, Li J, Xie X, Lian X, Zhang Z, Cao Y, Yin W, Jin R. Song R, et al. Among authors: zeng g. Emerg Microbes Infect. 2023 Dec;12(1):2212806. doi: 10.1080/22221751.2023.2212806. Emerg Microbes Infect. 2023. PMID: 37157134 Free PMC article. Clinical Trial.
Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial.
Yang W, González PA, Xin Q, Reyes MRL, Villalobos RE, Borja-Tabora CFC, Bermal NN, Kalergis AM, Yu D, Wu W, Bueno SM, Huo L, Calvo M, Qinf Study Group, Zeng G, Li J. Yang W, et al. Among authors: zeng g. Vaccines (Basel). 2024 Aug 7;12(8):892. doi: 10.3390/vaccines12080892. Vaccines (Basel). 2024. PMID: 39204018 Free PMC article.
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trial.
Jin P, Liu Q, Chen W, Guo X, Jiang H, Zhang R, Ding M, Zhang K, Cao Z, He J, Jia S, Wei M, Hu Y, Cui L, Wang J, Li Z, Zhang X, Xia X, Wu Y, Zhou L, Zhu Y, Gao C, Zhang T, Zhu F, Zeng G, Zhu L, Li J. Jin P, et al. Among authors: zeng g. Expert Rev Vaccines. 2024 Jan-Dec;23(1):1041-1051. doi: 10.1080/14760584.2024.2425283. Epub 2024 Nov 11. Expert Rev Vaccines. 2024. PMID: 39523878 Free article. Clinical Trial.
4,025 results